Failure of Alpha Tocopherol to Influence Chest Pain in Patients with Heart Disease
- 1 February 1950
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 1 (2) , 288-293
- https://doi.org/10.1161/01.cir.1.2.288
Abstract
Claims for vitamin E in angina pectoris have not been based on controlled observations. Even some negative reports have not been adequately controlled as to nonspecific factors. Hence, this study of the effects of alpha tocopherol on cardiac pain used a method of investigation carefully controlled as to psychologic factors which might affect the patient's response or the examiner's interpretation of results. The dose of synthetic alpha tocopherol acetate (300 mg. by mouth daily for two or more months) was the same as that recommended by advocates of this form of therapy as optimum in most cases. The results failed to indicate that the vitamin possessed any advantage over the placebo for treatment of either effort angina or mixed types of cardiac and somatic chest pain.Keywords
This publication has 19 references indexed in Scilit:
- Cardiac painThe American Journal of Medicine, 1948
- The effect of intravenous aminophylline on the capacity for effort without pain in patients with angina of effortAmerican Heart Journal, 1948
- VITAMIN E IN HEART DISEASEAnnals of Internal Medicine, 1948
- THE USE OF VITAMIN E IN HEART DISEASEThe Lancet Healthy Longevity, 1948
- Therapy directed at the somatic component of cardiac painAmerican Heart Journal, 1948
- VITAMIN E IN ANGINA PECTORISThe Lancet, 1948
- VITAMIN E IN ANGINA PECTORISThe Lancet, 1948
- Treatment of some chronic muscular diseasesThe American Journal of Medicine, 1947
- Vitamin E in the treatment of muscle disorders of infancy and childhoodThe Journal of Pediatrics, 1941
- VITAMIN E IN THE TREATMENT OF FIBROSITISThe Lancet Healthy Longevity, 1941